Announcements Trials

Browse Landscape

Phase

Phase EARLY_PHASE1 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Breast Neoplasms 25 Neoplasms 12 Stomach Neoplasms 10 Endometrial Neoplasms 10 Lung Neoplasms 9 Lymphatic Metastasis 7 Melanoma 6 Head and Neck Neoplasms 6 Carcinoma, Hepatocellular 6 Uterine Cervical Neoplasms 5 Rectal Neoplasms 5 Esophageal Neoplasms 5 Colonic Neoplasms 5 Carcinoma, Non-Small-Cell Lung 5 Vulvar Neoplasms 3 Sarcoma 3 Prostatic Neoplasms 3 Ovarian Neoplasms 3 Colorectal Neoplasms 3 Thyroid Neoplasms 2 Squamous Cell Carcinoma of Head and Neck 2 Skull Base Neoplasms 2 Sarcoma, Ewing 2 Rhabdomyosarcoma 2 Peritoneal Neoplasms 2 Osteosarcoma 2 Margins of Excision 2 Lymphedema 2 Hypoparathyroidism 2 Giant Cell Tumor of Bone 2

Interventions

talimogene laherparepvec 1 exemestane 1 Therapeutics 1 Telomerase 1 Tamoxifen 1 Surgical Procedures, Operative 1 Specimen Handling 1 Sentinel Lymph Node Biopsy 1 Radiation, Ionizing 1 Paclitaxel 1 Mastectomy, Subcutaneous 1 Mastectomy, Segmental 1 Mammaplasty 1 Letrozole 1 Indocyanine Green 1 Brachytherapy 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

OTHER × Carcinoma, Ductal × Indocyanine Green × Clear all

NCT01796041 2021-01-28

ICG

Abramson Cancer Center at Penn Medicine

Phase EARLY_PHASE1 Completed

Carcinoma, Lobular, Carcinoma, Ductal

Data powered by HemOnc (CC BY 4.0) Colophon ⚡